Archives

To view these presentation slides, please click on DMF Registration in China. Read More

As China’s drug market grows exponentially, more foreign API, excipient and drug packaging material companies look to sell their products in China. In August 2016, to simplify the drug review procedure, the former CFDA announced that the review and approval of APIs,... Read More

Systematic evaluations of the effects of health technologies in Japan, China, and South Korea conducted over the past three years are showing success in determining the clinical benefits and cost-effectiveness of widely used drugs, adjusting pricing of drugs and medical devices and... Read More

In a bid to reduce prices of sorely needed medical devices, China is set to expand a trial bulk purchase program that has made coronary stents, pacemakers, prosthetics and other medical devices more affordable in the provinces of Jiangsu and Anhui. Under... Read More

Seeking to more effectively manage, distribute and ensure the efficacy of publicly funded vaccines, Chinese health authorities plan to institute a web-based national vaccine tracking system in the next three months. The system, piloted in seven major provinces last year, is designed... Read More

This article was originally published on MedTech Intelligence. Driven by an aging population with growing needs for new medical technologies—and more means to pay for them—governments and hospitals in China, Japan, Singapore, Thailand and Korea are joining forces to purchase an increasing... Read More

New drug therapies to treat serious and life-threatening diseases would be reviewed more quickly under draft regulations under consideration by China’s Center for Drug Evaluation (CDE). The proposed guidelines would allow for priority review and conditional approval of pharmaceuticals deemed to have... Read More

Pushing to increase the ability of China’s medical institutions to conduct much-needed medical device and drug trials without sacrificing safety or quality, the National Medical Products Administration added more than 150 medical institutions to the list of those certified to host clinical... Read More

Chronic health disorders linked to obesity, smoking, high salt intake, and pollution are mounting in China, as Asia’s largest economy grapples with the burdens of rapid growth and affluence. A new study published in the Lancet finds chronic illnesses including stroke, hypertension,... Read More

With the goal of raising the quality and accessibility of its healthcare system to a level commensurate with its position as the world’s second-largest economy, the Chinese government has in the past five years doubled the money it pours into public hospitals... Read More